Ourania Tatsis $VRTX SEC Form 4 Insider Trading

Ourania Tatsis has filed a total of 50 insider trades in $VRTX since 2021. Their most recent trade was a sale of 3,242 shares, made on Mar 10, 2025. Their largest trade was a sale of 5,750 shares, made on Aug 10, 2023. We estimate that they now own 51,239 shares of $VRTX, worth an estimated $23.4 million.

Insider Trading at $VRTX

There have been a total of 493 insider trades reported at $VRTX since 2021, with 25,000 shares purchased and 847,189 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 3,231 shares reported by DAVID ALTSHULER (EVP, Chief Scientific Officer), made on Mar 13, 2025.

$VRTX Executives and Stock Owners with Insider Trades

• David Altshuler, EVP, Global Research and CSO

• Bastiano Sanna, EVP, Cell & Genetic Therapies

• Ourania Tatsis, EVP, Chief Reg. & Quality Off.

• Stuart A Arbuckle, EVP, COO

• Charles F Jr Wagner, EVP & Chief Financial Officer

• Jeffrey M Leiden, Executive Chairman

• Joy Liu, SVP, General Counsel

• Reshma Kewalramani, CEO & President

• Kristen Ambrose, SVP & Chief Accounting Officer

• Carmen Bozic, EVP and CMO

• David Altshuler, EVP, Chief Scientific Officer

• Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.

• Amit Sachdev, EVP Chief Patient & Ext Af Off

• Jonathan Biller, EVP and Chief Legal Officer

• Amit Sachdev, EVP, Chief Patient Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.